Regulatory Advocacy

The AAO-HNS has a long history of working closely with regulatory agencies (e.g., Centers for Medicare & Medicaid Services, U.S. Food and Drug Administration) to maintain our visibility and credibility with national representatives regarding federal regulatory issues.

We believe that advocacy is the key to defining the future of otolaryngology. Federal regulatory advocacy is a top priority of the AAO-HNS.

Academy Comments on Proposed CY 2016 HOPPS (8/31/15)
The Academy submitted comments on the proposed rule for CY 2016 Hospital Outpatient Prospective Payment System (HOPPS) and Ambulatory Surgical Center (ASC) Payment Rate that are specifc to the Otolaryngology community. The Academy commented on: point-of-care imaging access for patients and changes to Ambulatory Payment Classifications assignments. To view the Academy comments, click the link below: 

Academy Summarizes Impact of CMS 2015 Proposed Policies on the Otolaryngology Community (8/6/2015)
The Academy has summarized payment rules and policies from the CY 2016 proposed Medicare Physician Fee Schedule (MPFS) that are specific to the Otolaryngology community. Issues include: practice expense proposed changes; improving valuation of the Global Surgical Package; Physician Compare, PQRS, and Value-Based Payment Modifier (VM) proposed changes; and modifications to the Qualified Clinical Data Registry (QCDR) qualification requirements. This is one of many federal policies that the Academy comments on to advocate for appropriate national policies on your behalf. To view the summary, click the link below: